Rachel Stenson

586 total citations
15 papers, 208 citations indexed

About

Rachel Stenson is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Rachel Stenson has authored 15 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Rachel Stenson's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (3 papers) and Pregnancy and Medication Impact (3 papers). Rachel Stenson is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (3 papers) and Pregnancy and Medication Impact (3 papers). Rachel Stenson collaborates with scholars based in United Kingdom, United States and Australia. Rachel Stenson's co-authors include David Gillespie, Kerenza Hood, G Thomas, A. B. Hawthorne, Imran Ahmad, James R. Wright, Geraint T. Williams, A. Daniels, G. Thomas and C Probert and has published in prestigious journals such as Gastroenterology, Gut and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Rachel Stenson

15 papers receiving 202 citations

Peers

Rachel Stenson

GENET

SURGE

EPIDE

PMH

Priya Narula United Kingdom

Yvonne LeFort United States

Christopher Alexakis United Kingdom

Monika Szpotanska‐Sikorska Poland

János Banai Hungary

Carla Demeterco‐Berggren United States

Marta Bassi Italy

Marisa G. Stahl United States

Priyanka Mathias United States

M. Dagorne France

Priya Narula United Kingdom

Rachel Stenson

52 ×0.6

GENET

92 ×1.3

SURGE

30 ×0.4

EPIDE

48 ×0.8

32 ×0.8

PMH

Citations per year, relative to Rachel Stenson Rachel Stenson (= 1×) peers Priya Narula

Countries citing papers authored by Rachel Stenson

Since Specialization

Citations

This map shows the geographic impact of Rachel Stenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Stenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Stenson more than expected).

Fields of papers citing papers by Rachel Stenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Stenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Stenson. The network helps show where Rachel Stenson may publish in the future.

Co-authorship network of co-authors of Rachel Stenson

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Stenson. A scholar is included among the top collaborators of Rachel Stenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Stenson. Rachel Stenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Brunner, Martina, Rachel Stenson, Piotr Jaroslaw Chmura, et al.. (2024). Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trial. BMJ Open. 14(11). e091597–e091597. 3 indexed citations

Gregory, John W, Kymberley Carter, WY Cheung, et al.. (2021). Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol. BMJ Open. 11(10). e049595–e049595. 7 indexed citations

Gillespie, David, Daniel Farewell, Peter Barrett‐Lee, et al.. (2017). The use of randomisation-based efficacy estimators in non-inferiority trials. Trials. 18(1). 5 indexed citations

Gillespie, David, Kerenza Hood, Daniel Farewell, et al.. (2015). The use of randomisation-based efficacy estimators in non-inferiority trials. Trials. 16(S2). 117–117. 3 indexed citations

Gillespie, David, Kerenza Hood, Daniel Farewell, et al.. (2013). Electronic Monitoring of Medication Adherence in a 1-year Clinical Study of 2 Dosing Regimens of Mesalazine for Adults in Remission with Ulcerative Colitis. Inflammatory Bowel Diseases. 20(1). 82–91. 21 indexed citations

Hawthorne, A. B., Rachel Stenson, David Gillespie, et al.. (2011). Once daily Asacol: Table 1. Gut. 60(Suppl 1). A37.2–A38. 4 indexed citations

Hawthorne, A. B., Rachel Stenson, David Gillespie, et al.. (2011). Once Daily Mesalazine as Maintenance Therapy for Ulcerative Colitis (UC): A One-Year Single-Blind Randomised Trial. Gastroenterology. 140(5). S–65. 6 indexed citations

Hawthorne, A. B., Rachel Stenson, David Gillespie, et al.. (2011). Assessment of Adherence to Mesalazine Maintenance Therapy Over One Year Using Mems® Monitoring System: A Substudy of the CODA trial Comparing Once Versus Three Times Daily Asacol® in Ulcerative Colitis (UC). Gastroenterology. 140(5). S–264. 2 indexed citations

Stenson, Rachel, David Gillespie, E T Swarbrick, et al.. (2011). One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis. Inflammatory Bowel Diseases. 18(10). 1885–1893. 23 indexed citations

10.

Gillespie, David, Kerenza Hood, Andrew Williams, et al.. (2011). The use of the Medication Event Monitoring System (MEMS) for assessing medication adherence for chronic conditions: use and results from a 12 month trial of patients in remission with ulcerative colitis (UC). Trials. 12(S1). 5 indexed citations

11.

Ahmad, Imran, Rachel Stenson, James R. Wright, et al.. (2003). Antibiotic prophylaxis for percutaneous endoscopic gastrostomy — a prospective, randomised, double‐blind trial. Alimentary Pharmacology & Therapeutics. 18(2). 209–215. 69 indexed citations

12.

Stenson, Rachel, et al.. (2000). Crohnʼs disease incidence in Cardiff from 1930: an update for 1991-1995. European Journal of Gastroenterology & Hepatology. 12(8). 907–911. 46 indexed citations

13.

Hawthorne, A. B., Sue Morgan, D. Westmoreland, et al.. (1999). A comparison of two rapid whole-blood tests and laboratory serology, in the diagnosis of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology. 11(8). 863–866. 8 indexed citations

14.

Chadha, M. S., et al.. (1994). Patients with human immunodeficiency virus (HIV) infections and cervical neoplasia. International Journal of Radiation Oncology*Biology*Physics. 30. 284–284. 1 indexed citations

15.

Cirisano, Frank D., Jeffrey S. Greenspoon, Rachel Stenson, et al.. (1993). The Etiology and Management of Diarrhea in the Gynecologic Oncology Patient. Gynecologic Oncology. 50(1). 45–48. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact